Control of IGF-I Gene Transcription in Osteoblasts
Control of IGF-I Gene Transcription in Osteoblasts
批准号:
6823246
负责人:
Peter S Rotwein
金额:
$26.58万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-01-01 至 2007-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
EXCEED THE SPACE PROVIDED. Insulin-like growth factor-I (IGF-I), a conserved 70-residue secreted protein, plays a fundamental role in somatic growth in mammals and other vertebrate species. Although much evidence has accumulated supporting IGF-I as a major postnatal growth factor, regulated at least in part by growth hormone, many studies have suggested a broader range of functions for this peptide, including actions on local tissue growth, maintenance, and repair throughout the life span. These observations in turn imply that control of IGF-I synthesis may be multi-factorial, responding not only to systemic hormonal signals but also to tissue- specific factors. IGF-I is produced by many cells including osteoblasts, and can act as a growth and differentiation factor within the skeleton as well as in other tissues. Recent studies implicating IGF-I as a key component of the anabolic effects of parathyroid hormone (PTH) on bone and establishing a role for PTH in increasing bone mass and preventing osteoporosis only underscore the importance of IGF-I in maintaining skeletal integrity. Since osteoporosis is a disorder of remodeling in which bone resorption outstrips formation, any insights into pathways that enhance bone mass have potential therapeutic implications. As part of a long-term effort to understand the mechanisms by which IGF-I synthesis is controUed under different physiological conditions, the focus of this application will be on regulation of IGF-I gene transcription in bone cells. Key goals will be to define the signal transduction pathways and molecular mechanisms by which PTH through cyclic AMP and protein kinase A controls IGF-t expression via the transcription factor, C/EBPdelta. Toward this end the following four Specific Aims are proposed: 1. To determine how PKA activates CIEBPdelta and stimulates its nuclear expression in osteoblasts. 2. To establish how PKA promotes the transcriptional activity of C/EBPdelta in bone cells. 3. To define mechanisms of termination of hormone-activated IGF-I transcription and down regulation of C/EBPdelta activity in osteoblasts. 4. To evaluate by gene profiling the role of C/EBPdelta in osteoblast biology. PERFORMANCE SiTE ========================================Section End===========================================
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Insulin-like Growth Factors and Muscle Differentiation
-
批准号:7993219
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2010
-
负责人:Peter S Rotwein
-
依托单位:
2009 Insulin-like Growth Factors in Physiology and Disease Gordon Research Confer
-
批准号:7612562
-
项目类别:
-
资助金额:$1.9万
-
财政年份:2009
-
负责人:Peter S Rotwein
-
依托单位:
2009 Insulin-like Growth Factors in Physiology and Disease Gordon Conference
-
批准号:8220895
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Peter S Rotwein
-
依托单位:
2009 Insulin-like Growth Factors in Physiology and Disease Gordon Research Confer
-
批准号:8049215
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2009
-
负责人:Peter S Rotwein
-
依托单位:
2009 Insulin-like Growth Factors in Physiology and Disease Gordon Conference
-
批准号:8423719
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2009
-
负责人:Peter S Rotwein
-
依托单位:
2009 Insulin-like Growth Factors in Physiology and Disease Gordon Research Confer
-
批准号:7769541
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Peter S Rotwein
-
依托单位:
Control of IGF-1 Gene Transcription by Growth Hormone
-
批准号:8501432
-
项目类别:
-
资助金额:$32.32万
-
财政年份:2006
-
负责人:Peter S Rotwein
-
依托单位:
Control of IGF-1 Gene Transcription by Growth Hormone
-
批准号:8193456
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2006
-
负责人:Peter S Rotwein
-
依托单位:
Control of IGF-1 Gene Transcription by Growth Hormone
-
批准号:7364414
-
项目类别:
-
资助金额:$13.85万
-
财政年份:2006
-
负责人:Peter S Rotwein
-
依托单位:
Control of IGF-1 Gene Transcription by Growth Hormone
-
批准号:7230524
-
项目类别:
-
资助金额:$29.87万
-
财政年份:2006
-
负责人:Peter S Rotwein
-
依托单位:
Control of IGF-1 Gene Transcription by Growth Hormone
-
批准号:7090960
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2006
-
负责人:Peter S Rotwein
-
依托单位:
Control of IGF-1 Gene Transcription by Growth Hormone
-
批准号:8690024
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2006
-
负责人:Peter S Rotwein
-
依托单位:
Control of IGF-1 Gene Transcription by Growth Hormone
-
批准号:8335463
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2006
-
负责人:Peter S Rotwein
-
依托单位:
Control of IGF-1 Gene Transcription by Growth Hormone
-
批准号:7568830
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2006
-
负责人:Peter S Rotwein
-
依托单位:
Control of IGF-1 Gene Transcription by Growth Hormone
-
批准号:7368100
-
项目类别:
-
资助金额:$42.89万
-
财政年份:2006
-
负责人:Peter S Rotwein
-
依托单位:
OHSU Medical Scientist Training Program
-
批准号:6592617
-
项目类别:
-
资助金额:$14.43万
-
财政年份:2004
-
负责人:Peter S Rotwein
-
依托单位:
OHSU Medical Scientist Training Program
-
批准号:6904505
-
项目类别:
-
资助金额:$19.24万
-
财政年份:2004
-
负责人:Peter S Rotwein
-
依托单位:
OHSU Medical Scientist Training Program
-
批准号:7065664
-
项目类别:
-
资助金额:$18.84万
-
财政年份:2004
-
负责人:Peter S Rotwein
-
依托单位:
Control of IGF-I Gene Transcription in Osteoblasts
-
批准号:6561367
-
项目类别:
-
资助金额:$26.58万
-
财政年份:2003
-
负责人:Peter S Rotwein
-
依托单位:
Control of IGF-I Gene Transcription in Osteoblasts
-
批准号:7001287
-
项目类别:
-
资助金额:$25.95万
-
财政年份:2003
-
负责人:Peter S Rotwein
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于铁死亡探讨IGF-BP-3在血管钙化中的作用及机制研究
-
批准号:JCZRLH202600166
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
黄精来源的外泌体靶向IGF2R调控巨噬细胞胞葬功能影响骨关节炎进展的作用机制研究
-
批准号:JCZRLH202601819
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
KAT6A介导IGF2BP2乙酰化在宫颈癌ICI治疗抵抗中的机制研究
-
批准号:JCZRLH202600764
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
OTUB1稳定m6A结合蛋白IGF2BP1参与心肌缺血再灌注损伤的机制研究
-
批准号:2026JJ81329
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘继佳
-
依托单位:
ac4C表观修饰IGF2R抑制cGAS-STING通路拮抗溃疡性结肠炎的分子机制研究
-
批准号:2026JJ50269
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈玲
-
依托单位:
IGF2BP2通过m6A甲基化修饰调控VEGF-C转录促进头颈鳞癌淋巴管生成的机制研究
-
批准号:JCZRQNB202600634
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
全基因组CRISPR/Cas9文库筛选发现IGF1R通过抑制细胞焦亡途径诱导结直肠癌奥沙利铂耐药的机制研究
-
批准号:2026JJ80578
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨熙华
-
依托单位:
环状RNAcircWEE1通过miR-942介导的IGF1和CDK6通路双重调控骨肉瘤顺铂耐药的作用机制研究
-
批准号:2026JJ80942
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚昊立
-
依托单位:
以“补益脾肾、泄浊祛瘀”为法通过 sKlotho 调控 IGF-1/PI3K/Akt 信号通路改善慢性肾脏病血管钙化研究
-
批准号:JCZRLH202600864
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
CXCL14激活IGF-1R-AKT-mTOR通路减轻脓毒症相关急性肾损伤的机制研究
-
批准号:JCZRLH202601010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: